Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Cancer Discovery|2023Cited by 91
A novel, high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways <i>ex vivo</i> and <i>in vivo</i>Sarah T. Diepstraten, Marco J. Herold|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Supplementary Data Figure S1 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Unknown|2024Cited by 0
Supplementary Data Figure S27 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Unknown|2024Cited by 0
Supplementary Data Figure S21 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Unknown|2024Cited by 0